GlaxoSmithKline Consumer Nigeria Plc has announced the selection of Fidson Healthcare Plc as its local content manufacturing partner as part of its restructuring exercise with effect from the third quarter of 2021. The new appointment followed an earlier announcement by GSK to restructure its supply chain operating model.
According to a statement by GSK Friday, the manufacturing of its wellness and respiratory products will be “transitioned” to Fidson Healthcare.
“Until then it would be business as usual at the Agbara factory plant as GSK continues to ensure supply continuity for all its locally manufactured brands,” the company said.
OLUFIKAYO OWOEYE
